Dr. Lal PathLabs (NSE:LALPATHLAB) Total Payout Ratio : 0.00 (As of Jun. 10, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Dr. Lal PathLabs Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Dr. Lal PathLabs's current Total Payout Ratio is 0.00.

Dr. Lal PathLabs Total Payout Ratio Historical Data

The historical data trend for Dr. Lal PathLabs's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr. Lal PathLabs Total Payout Ratio Chart

Dr. Lal PathLabs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Payout Ratio

Get a 7-Day Free Trial

0.68

0.34

0.33

0.42

0.55

Dr. Lal PathLabs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Dr. Lal PathLabs's Total Payout Ratio

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Lal PathLabs's Total Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Total Payout Ratio falls into.

Dr. Lal PathLabs Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Dr. Lal PathLabs's Total Payout Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	34.88	+	-2011.69)	/	3622.93
	=	0.55

Dr. Lal PathLabs's Total Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	845.35
	=	0.00

Dr. Lal PathLabs Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Dr. Lal PathLabs's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr. Lal PathLabs (NSE:LALPATHLAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dr. Lal PathLabs Ltd (NSE:LALPATHLAB) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

539524:India

Address

12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001

Website

https://www.lalpathlabs.com

Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the area of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist to prevent, monitor and treat diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.

Dr. Lal PathLabs (NSE:LALPATHLAB) Headlines

No Headlines